Nanogen, Inc., a San Diego-based diagnostics company, develops and sells diagnostic test kits and reagents for in-vitro use, including cardiac and influenza tests.
Nanogen, Inc., founded in San Diego, focuses on developing, manufacturing, and selling diagnostic products for the in vitro diagnostic market. The company's core mission is to enhance healthcare through innovative diagnostic solutions. Nanogen offers a range of diagnostic test kits and reagents based on polymerase chain reaction (PCR) technology, including Q-PCR Alert products for cardiac and influenza testing. Their products are marketed primarily in the United States, Canada, and Europe.
Notable affiliated individuals include key scientists and industry experts who have contributed to the development of their advanced diagnostic technologies. Nanogen has secured investments from prominent venture capital firms, aiding in its research and market expansion. The company has achieved significant milestones in molecular diagnostics, particularly in PCR technology, impacting the healthcare industry by providing reliable and rapid diagnostic tools.
